8-K - Arcus Biosciences, Inc. (0001724521) (Filer)
Published . Updated .
8-K - Arcus Biosciences filed an 8-K with the SEC on Oct 23 (a notice of a material company event).
Directly affected
- RCUS Arcus Biosciences-19.5%
Named in this report.
Indirectly affected
- No related companies are mapped for this report yet.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| RCUS | +19.43% | +2.97% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-23 AccNo: 0001724521-26-000050 Size: 471 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Arcus Biosciences (RCUS) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| GLD | three days earlier | +3.41% | final price |
| GLD | five days earlier | +3.59% | final price |
| QQQ | three days earlier | +2.96% | final price |
| QQQ | five days earlier | +1.97% | final price |
| Arcus Biosciences (RCUS) | three days earlier | +2.97% | final price |
| Arcus Biosciences (RCUS) | five days earlier | +19.43% | final price |
| SPY | three days earlier | +1.68% | final price |
| SPY | five days earlier | +0.82% | final price |
| TLT | three days earlier | -1.30% | final price |
| TLT | five days earlier | -2.26% | final price |
Who gains and who loses around Arcus Biosciences (RCUS)
Companies carried with this story
- RCUS Arcus Biosciences
In “8-K - Arcus Biosciences, Inc. (0001724521) (Filer),” Arcus Biosciences (RCUS) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> RCUS
How “8-K - Arcus Biosciences, Inc. (0001724521) (Filer)” reaches Arcus Biosciences (RCUS)
The 23 Oct 2026 story “8-K - Arcus Biosciences, Inc. (0001724521) (Filer)” names Arcus Biosciences (RCUS) because of this story.
What ties Arcus Biosciences (RCUS) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> RCUS
Price levels for Arcus Biosciences (RCUS)
RCUS traded between 17.68 and 26.35 across 11 sessions. The latest close on file is 19.36.
How strong the case is around Arcus Biosciences (RCUS)
14 out of 100
“8-K - Arcus Biosciences, Inc. (0001724521) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.